TELO logo

Telomir Pharmaceuticals, Inc. Common Stock

TELO
Healthcare|Biotechnology|US
$0.71
-0.07 (-8.97%)
DCF Value
$0.20
Tangible Book / Share
$0.06
Cash / Share
$0.07

Ownership Breakdown

53.2%
Float
73.7M
Shares Outstanding
39.2M
Float Shares

Major Holders (1)

Combined: 5.2%

Holders of 5%+ from their latest Schedule 13D/13G filing in the last two years. Percentages are as of each filing date.

HolderType% of ClassSharesFiledFiling
John Paul DeJoria, as trustee of the John Paul DeJoria Family Trust, and in his individual capacityIndividual5.17%3,554,871Aug 14, 202613D/G

Insider Trades (50)

Last 4 quarters: 13,754,880 acquired · 4,135,170 disposed
InsiderPositionDateTypeSharesPriceValueFiling
Whalen Matthew PrattdirectorApr 16, 2026AWARD50,000$1.34$67.0KForm 4
MacPherson Edward CloustondirectorApr 16, 2026AWARD50,000$1.34$67.0KForm 4
Del Giudice Matthew PauldirectorApr 16, 2026AWARD50,000$1.34$67.0KForm 4
Mushak AndriyofficerJun 3, 2026OTHER0——Form 4
Aminov Erezdirector, officer: CEO and ChairmanMay 21, 2026AWARD2,000,000$1.30$2.6MForm 4
Aminov Erezdirector, officer: CEO and ChairmanMay 21, 2026AWARD1,960,170$1.30$2.5MForm 4
Aminov Erezdirector, officer: CEO and ChairmanMay 21, 2026DISPOSED1,960,170$5.02$9.8MForm 4
Aminov Erezdirector, officer: CEO and ChairmanMay 21, 2026DISPOSED2,000,000$2.10$4.2MForm 4
Whalen Matthew PrattdirectorMay 21, 2026AWARD25,000$1.30$32.5KForm 4
Whalen Matthew PrattdirectorMay 21, 2026DISPOSED25,000$5.02$125.5KForm 4
MacPherson Edward CloustondirectorMay 21, 2026AWARD25,000$1.30$32.5KForm 4
MacPherson Edward CloustondirectorMay 21, 2026DISPOSED25,000$5.02$125.5KForm 4
Del Giudice Matthew PauldirectorMay 21, 2026AWARD25,000$1.30$32.5KForm 4
Del Giudice Matthew PauldirectorMay 21, 2026DISPOSED25,000$5.02$125.5KForm 4
Aminov Erezdirector, officer: CEO and ChairmanApr 22, 2026J7,319,710$1.37$10.0MForm 4
MIRA PHARMACEUTICALS, INC.10 percent ownerSep 29, 2025OTHER0——Form 4
Weichselbaum AlanChief Financial OfficerMay 15, 2025OTHER50,000$2.75$137.5KForm 4
Aminov Erezdirector, officer: CEO and ChairmanMay 28, 2025AWARD2,000,000$2.10$4.2MForm 4
Aminov Erezdirector, officer: CEO and ChairmanMay 28, 2025AWARD400,000——Form 4
Aminov Erezdirector, officer: CEO and ChairmanAug 19, 2024SELL200$6.01$1.2KForm 4
Aminov Erezdirector, officer: CEO and ChairmanAug 19, 2024SELL200$6.20$1.2KForm 4
Aminov Erezdirector, officer: CEO and ChairmanDec 31, 2024OTHER0——Form 4
Bay Shore Trust10 percent ownerNov 21, 2024GIFT100,000$3.73$373.0KForm 4
Yanez MichelleChief Financial OfficerAug 27, 2024AWARD200,000$5.02$1.0MForm 4
Jerman Michael AllendirectorAug 27, 2024AWARD25,000$5.02$125.5KForm 4
MacPherson Edward CloustondirectorAug 27, 2024AWARD25,000$5.02$125.5KForm 4
Aminov Erezdirector, officer: CEO & ChairmanAug 27, 2024AWARD1,960,170$5.02$9.8MForm 4
Del Giudice Matthew PauldirectorAug 27, 2024AWARD25,000$5.02$125.5KForm 4
Whalen Matthew PrattdirectorAug 27, 2024AWARD25,000$5.02$125.5KForm 4
Yanez MichelleChief Financial OfficerJun 18, 2024OTHER0——Form 4
Del Giudice Matthew Pauldirector: Aug 8, 2024OTHER0——Form 4
Whalen Matthew Prattdirector: Aug 8, 2024OTHER0——Form 4
Aminov Erezdirector, officer: CEO & ChairmanAug 8, 2024OTHER0——Form 4
MacPherson Edward Cloustondirector: Aug 8, 2024OTHER0——Form 4
Bay Shore Trust10 percent ownerFeb 13, 2024BUY49,000$7.00$343.0KForm 4
Bay Shore Trust10 percent ownerFeb 13, 2024BUY49,000$7.00$343.0KForm 4
Bay Shore Trust10 percent ownerFeb 13, 2024BUY40,000$7.00$280.0KForm 4
Bay Shore Trust10 percent ownerFeb 8, 2024OTHER0——Form 4
Bay Shore Trust10 percent ownerFeb 8, 2024OTHER0——Form 4
Bay Shore Trust10 percent ownerFeb 8, 2024OTHER0——Form 4
Bay Shore Trust10 percent ownerFeb 8, 2024OTHER0——Form 4
Bay Shore Trust10 percent ownerJun 15, 2023OTHER2,439,025$3.73$9.1MForm 4
Tuck TalhiadirectorFeb 8, 2024OTHER0——Form 4
Fuentes NathenChief Financial OfficerFeb 8, 2024OTHER0——Form 4
Jerman Michael AllenFeb 8, 2024OTHER0——Form 4
McColl Hugh IIIdirectorFeb 8, 2024OTHER0——Form 4
EAGLE CRAIGdirectorFeb 8, 2024OTHER0——Form 4
Nicholoudis ChristosFeb 8, 2024OTHER0——Form 4
Chapman Christopher C JRdirector, officer: CEO & ChairmanFeb 8, 2024OTHER0——Form 4
Kroenig BradleydirectorFeb 8, 2024OTHER0——Form 4